FDA Issues Class II Recall for Duloxetine Capsules Over Health Concerns

The FDA has issued a Class II recall for over 7,100 bottles of Duloxetine Delayed-Release Capsules due to elevated levels of a harmful chemical, N-nitroso-duloxetine. Patients are urged to consult healthcare professionals before making any changes to their medication. This recall highlights the FDA’s commitment to drug safety and public health.